LENZ Therapeutics, Inc. (LENZ) Return on Equity (2022 - 2023)
LENZ Therapeutics (LENZ) has disclosed Return on Equity for 2 consecutive years, with 1.29% as the latest value for Q3 2023.
LENZ Therapeutics (LENZ) has disclosed Return on Equity for 2 consecutive years, with 1.29% as the latest value for Q3 2023.